RTS , S/AS01 lots formulated from commercial-scale purified antigen bulk batches induced a consistent anti-CS antibody response , and the anti-CS GMT of pooled commercial-scale lots was non-inferior to that of a lot formulated from a pilot-scale antigen bulk batch .